Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation.

Adipose tissue is a critical mediator in obesity-induced insulin resistance. Previously we have demonstrated that pharmacological lowering of glycosphingolipids and subsequently GM3 by using the iminosugar AMP-DNM, strikingly improves glycemic control. Here we studied the effects of AMP-DNM on adipo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marco van Eijk, Jan Aten, Nora Bijl, Roelof Ottenhoff, Cindy P A A van Roomen, Peter F Dubbelhuis, Ingar Seeman, Karen Ghauharali-van der Vlugt, Hermen S Overkleeft, Cynthia Arbeeny, Albert K Groen, Johannes M F G Aerts
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2009
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4de7292dc62c4bccba10a1b9b8fc6b87
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4de7292dc62c4bccba10a1b9b8fc6b87
record_format dspace
spelling oai:doaj.org-article:4de7292dc62c4bccba10a1b9b8fc6b872021-11-25T06:16:32ZReducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation.1932-620310.1371/journal.pone.0004723https://doaj.org/article/4de7292dc62c4bccba10a1b9b8fc6b872009-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19305508/?tool=EBIhttps://doaj.org/toc/1932-6203Adipose tissue is a critical mediator in obesity-induced insulin resistance. Previously we have demonstrated that pharmacological lowering of glycosphingolipids and subsequently GM3 by using the iminosugar AMP-DNM, strikingly improves glycemic control. Here we studied the effects of AMP-DNM on adipose tissue function and inflammation in detail to provide an explanation for the observed improved glucose homeostasis. Leptin-deficient obese (Lep(Ob)) mice were fed AMP-DNM and its effects on insulin signalling, adipogenesis and inflammation were monitored in fat tissue. We show that reduction of glycosphingolipid biosynthesis in adipose tissue of Lep(Ob) mice restores insulin signalling in isolated ex vivo insulin-stimulated adipocytes. We observed improved adipogenesis as the number of larger adipocytes was reduced and expression of genes like peroxisome proliferator-activated receptor (PPAR) gamma, insulin responsive glucose transporter (GLUT)-4 and adipsin increased. In addition, we found that adiponectin gene expression and protein were increased by AMP-DNM. As a consequence of this improved function of fat tissue we observed less inflammation, which was characterized by reduced numbers of adipose tissue macrophages (crown-like structures) and reduced levels of the macrophage chemo attractants monocyte-chemoattractant protein-1 (Mcp-1/Ccl2) and osteopontin (OPN). In conclusion, pharmacological lowering of glycosphingolipids by inhibition of glucosylceramide biosynthesis improves adipocyte function and as a consequence reduces inflammation in adipose tissue of obese animals.Marco van EijkJan AtenNora BijlRoelof OttenhoffCindy P A A van RoomenPeter F DubbelhuisIngar SeemanKaren Ghauharali-van der VlugtHermen S OverkleeftCynthia ArbeenyAlbert K GroenJohannes M F G AertsPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 4, Iss 3, p e4723 (2009)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marco van Eijk
Jan Aten
Nora Bijl
Roelof Ottenhoff
Cindy P A A van Roomen
Peter F Dubbelhuis
Ingar Seeman
Karen Ghauharali-van der Vlugt
Hermen S Overkleeft
Cynthia Arbeeny
Albert K Groen
Johannes M F G Aerts
Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation.
description Adipose tissue is a critical mediator in obesity-induced insulin resistance. Previously we have demonstrated that pharmacological lowering of glycosphingolipids and subsequently GM3 by using the iminosugar AMP-DNM, strikingly improves glycemic control. Here we studied the effects of AMP-DNM on adipose tissue function and inflammation in detail to provide an explanation for the observed improved glucose homeostasis. Leptin-deficient obese (Lep(Ob)) mice were fed AMP-DNM and its effects on insulin signalling, adipogenesis and inflammation were monitored in fat tissue. We show that reduction of glycosphingolipid biosynthesis in adipose tissue of Lep(Ob) mice restores insulin signalling in isolated ex vivo insulin-stimulated adipocytes. We observed improved adipogenesis as the number of larger adipocytes was reduced and expression of genes like peroxisome proliferator-activated receptor (PPAR) gamma, insulin responsive glucose transporter (GLUT)-4 and adipsin increased. In addition, we found that adiponectin gene expression and protein were increased by AMP-DNM. As a consequence of this improved function of fat tissue we observed less inflammation, which was characterized by reduced numbers of adipose tissue macrophages (crown-like structures) and reduced levels of the macrophage chemo attractants monocyte-chemoattractant protein-1 (Mcp-1/Ccl2) and osteopontin (OPN). In conclusion, pharmacological lowering of glycosphingolipids by inhibition of glucosylceramide biosynthesis improves adipocyte function and as a consequence reduces inflammation in adipose tissue of obese animals.
format article
author Marco van Eijk
Jan Aten
Nora Bijl
Roelof Ottenhoff
Cindy P A A van Roomen
Peter F Dubbelhuis
Ingar Seeman
Karen Ghauharali-van der Vlugt
Hermen S Overkleeft
Cynthia Arbeeny
Albert K Groen
Johannes M F G Aerts
author_facet Marco van Eijk
Jan Aten
Nora Bijl
Roelof Ottenhoff
Cindy P A A van Roomen
Peter F Dubbelhuis
Ingar Seeman
Karen Ghauharali-van der Vlugt
Hermen S Overkleeft
Cynthia Arbeeny
Albert K Groen
Johannes M F G Aerts
author_sort Marco van Eijk
title Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation.
title_short Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation.
title_full Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation.
title_fullStr Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation.
title_full_unstemmed Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation.
title_sort reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation.
publisher Public Library of Science (PLoS)
publishDate 2009
url https://doaj.org/article/4de7292dc62c4bccba10a1b9b8fc6b87
work_keys_str_mv AT marcovaneijk reducingglycosphingolipidcontentinadiposetissueofobesemicerestoresinsulinsensitivityadipogenesisandreducesinflammation
AT janaten reducingglycosphingolipidcontentinadiposetissueofobesemicerestoresinsulinsensitivityadipogenesisandreducesinflammation
AT norabijl reducingglycosphingolipidcontentinadiposetissueofobesemicerestoresinsulinsensitivityadipogenesisandreducesinflammation
AT roelofottenhoff reducingglycosphingolipidcontentinadiposetissueofobesemicerestoresinsulinsensitivityadipogenesisandreducesinflammation
AT cindypaavanroomen reducingglycosphingolipidcontentinadiposetissueofobesemicerestoresinsulinsensitivityadipogenesisandreducesinflammation
AT peterfdubbelhuis reducingglycosphingolipidcontentinadiposetissueofobesemicerestoresinsulinsensitivityadipogenesisandreducesinflammation
AT ingarseeman reducingglycosphingolipidcontentinadiposetissueofobesemicerestoresinsulinsensitivityadipogenesisandreducesinflammation
AT karenghauharalivandervlugt reducingglycosphingolipidcontentinadiposetissueofobesemicerestoresinsulinsensitivityadipogenesisandreducesinflammation
AT hermensoverkleeft reducingglycosphingolipidcontentinadiposetissueofobesemicerestoresinsulinsensitivityadipogenesisandreducesinflammation
AT cynthiaarbeeny reducingglycosphingolipidcontentinadiposetissueofobesemicerestoresinsulinsensitivityadipogenesisandreducesinflammation
AT albertkgroen reducingglycosphingolipidcontentinadiposetissueofobesemicerestoresinsulinsensitivityadipogenesisandreducesinflammation
AT johannesmfgaerts reducingglycosphingolipidcontentinadiposetissueofobesemicerestoresinsulinsensitivityadipogenesisandreducesinflammation
_version_ 1718413980789112832